---
figid: PMC6910185__fphar-10-01336-g006
figtitle: Schematic representation of antiangiogenic activity of genistein (Gen) in
  cancer
organisms:
- Glycine max
- Vicia faba
- Genista tinctoria
- Calluna vulgaris
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Escherichia coli
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Glycine max
- Drosophila melanogaster
pmcid: PMC6910185
filename: fphar-10-01336-g006.jpg
figlink: /pmc/articles/PMC6910185/figure/f6/
number: F6
caption: Schematic representation of antiangiogenic activity of genistein (Gen) in
  cancer. Genistein inactivates each of mitogen-activated protein kinases (MAPK),
  activator protein-1 (AP-1), Akt/NF-κB, and Erk1/2 pathways, which abolished the
  downstream matrix metalloproteinase-9 (MMP-9) synthesis at the transcription level
  that declines the proteolytic activity and impairs the cellular migration. Although
  focal adhesion kinase (FAK) would prevent apoptosis through inactivation of the
  cytosolic phospholipase A2 (PLA2) and p53, but it would mediate apoptosis through
  the activation of PI3K/Act pathway. Genistein inhibits the activation of proangiogenic
  proteins (ERK/Akt/mTOR). Genistein could prevent cell differentiation and proliferation
  by increasing the activity of the tumor suppressor PTEN, which blocks Akt activation
  though PI3K dephosphorylation, and also dephosphorylate PIP3 into phosphatidylinositol
  4,5-bisphosphate (PIP2). Genistein also prevents metastasis and enforces cancer
  cells to colonization in their site by phosphoprotein (VASP) upregulation. Since,
  VASP activates the extracellular matrix (ECM)-mediated β1-integrin-FAK-RhoA–YAP1-TAZ
  signaling to enhance YAP1/TAZ protein abundance. Genistein inactivates the epithelial–mesenchymal-transition
  (EMT) proteins, which promotes metastasis, including the proangiogenesis factors
  HIF-1α and vascular endothelial growth factor (VEGF), all are upregulated by hypoxia.
  Genistein downregulates PI3K/Akt/HIF-1α and NF-κB signaling pathways. Cycloxygenase-2
  (COX-2) regulates the production of prostaglandin E2 (PGE2) from arachidonic acid
  (AA). PGE2-pAkt axis is involved in regulation of MMP-2 activity, which, in turn,
  induces angiogenesis.
papertitle: 'Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.'
reftext: Hardeep Singh Tuli, et al. Front Pharmacol. 2019;10:1336.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9591333
figid_alias: PMC6910185__F6
figtype: Figure
redirect_from: /figures/PMC6910185__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6910185__fphar-10-01336-g006.html
  '@type': Dataset
  description: Schematic representation of antiangiogenic activity of genistein (Gen)
    in cancer. Genistein inactivates each of mitogen-activated protein kinases (MAPK),
    activator protein-1 (AP-1), Akt/NF-κB, and Erk1/2 pathways, which abolished the
    downstream matrix metalloproteinase-9 (MMP-9) synthesis at the transcription level
    that declines the proteolytic activity and impairs the cellular migration. Although
    focal adhesion kinase (FAK) would prevent apoptosis through inactivation of the
    cytosolic phospholipase A2 (PLA2) and p53, but it would mediate apoptosis through
    the activation of PI3K/Act pathway. Genistein inhibits the activation of proangiogenic
    proteins (ERK/Akt/mTOR). Genistein could prevent cell differentiation and proliferation
    by increasing the activity of the tumor suppressor PTEN, which blocks Akt activation
    though PI3K dephosphorylation, and also dephosphorylate PIP3 into phosphatidylinositol
    4,5-bisphosphate (PIP2). Genistein also prevents metastasis and enforces cancer
    cells to colonization in their site by phosphoprotein (VASP) upregulation. Since,
    VASP activates the extracellular matrix (ECM)-mediated β1-integrin-FAK-RhoA–YAP1-TAZ
    signaling to enhance YAP1/TAZ protein abundance. Genistein inactivates the epithelial–mesenchymal-transition
    (EMT) proteins, which promotes metastasis, including the proangiogenesis factors
    HIF-1α and vascular endothelial growth factor (VEGF), all are upregulated by hypoxia.
    Genistein downregulates PI3K/Akt/HIF-1α and NF-κB signaling pathways. Cycloxygenase-2
    (COX-2) regulates the production of prostaglandin E2 (PGE2) from arachidonic acid
    (AA). PGE2-pAkt axis is involved in regulation of MMP-2 activity, which, in turn,
    induces angiogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Vegfa
  - Hif1a
  - Pten
  - Ptk2
  - Vasp
  - Prkcg
  - Map2k3
  - Rhoa
  - Rho
  - Pik3cg
  - Src
  - Mapk14
  - Mapk8
  - Akt1
  - Cdh1
  - Fzr1
  - Tafazzin
  - Yap1
  - Mtor
  - Tp53
  - Hsp90aa1
  - Kras
  - Stat3
  - Ptgs2
  - Mapk3
  - Mapk1
  - Mdm2
  - Mmp2
  - Cdkn1b
  - Tmed7
  - Fos
  - Mmp9
  - Rhod
  - Ea2
  - Pik3r1
  - Map3k1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - H2-Aa
  - Wwtr1
  - Trp53
  - Hsp90ab1
  - Hsp84-2
  - Hsp84-3
  - Hsp86-ps2
  - Hsp86-ps1
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Pt
  - Dctn6
  - Psmd9
  - Pgr
  - Rb1
  - Jun
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - GEN1
  - HIF1A
  - PTEN
  - PTK2
  - VASP
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAP2K3
  - RHOA
  - RHO
  - RHOD
  - RHOB
  - RHOC
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP3K1
  - SRC
  - FGR
  - FYN
  - YES1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - CDH1
  - FZR1
  - TAFAZZIN
  - WWTR1
  - YAP1
  - MTOR
  - TP53
  - TP63
  - TP73
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - STAT3
  - PTGS2
  - MAPK3
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - MDM2
  - MMP2
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - RB1
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - JUN
  - JUNB
  - JUND
  - MMP9
  - ETM2
  - LOC547983
  - MEKK
  - cox2
  - COX2
  - AP1
  - SOYAP1
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Gen
  - sima
  - Fak
  - ena
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - lic
  - Rho1
  - rho
  - Bx
  - Lcp65Ab1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Mekk1
  - Src42A
  - Csk
  - Src64B
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - aa
  - Pla
  - Akt
  - shg
  - Taz
  - Dis3
  - Tor
  - p53
  - betaTub60D
  - hth
  - Hsp83
  - Gp93
  - dap
  - rl
  - Stat92E
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - DCTN6-p27
  - CG9588
  - rb
  - kay
  - AP-1gamma
  - Jra
  - PLA
  - PGE
---
